首页> 外文期刊>Head and neck: Journal for the sciences and specialities of the head and neck >Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation
【24h】

Outcome of patients with early T1 and T2 squamous cell carcinoma of the base of tongue managed by conventional surgery with adjuvant postoperative radiation

机译:常规术后辅以辅助放射治疗的舌根部早期T1和T2鳞状细胞癌患者的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background Existing treatment regimens for squamous cell carcinoma (SCC) of the base of tongue (BOT) favor chemoradiation. However, there is a shifting paradigm toward minimally invasive surgery with adjuvant radiatiotherapy for select tumors. The aim was to report our experience in conventional surgical management with particular focus on T1/T2 tumors, which may be candidates for minimally invasive techniques. Methods Between 1985 and 2005, 128 patients were treated with primary surgery. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) rates were calculated using Kaplan-Meier method, and predictive factors analyzed by univariate and multivariate analyses. Results Five-year OS, DSS, and RFS rates were 60%, 70%, and 61%, respectively. Multivariate analysis showed pathologic T classification and extracapsular extension (ECE) were significant predictors for DSS, whereas T classification remained significant for local recurrence. DSS for T1/T2 tumors ranged from 77% (node-positive) to 84% (node-negative). Conclusion T classification and ECE are independent predictors of outcome for BOT SCC. Patients with cT1/T2 tumors had excellent outcome and may be suitable for transoral robotic or endoscopic surgical procedures.
机译:背景技术现有的舌根鳞状细胞癌(BOT)鳞状细胞癌(SCC)治疗方案有利于放化疗。然而,针对选择的肿瘤,正在朝着微创手术和辅助放射疗法转移范式。目的是报告我们在常规外科手术治疗中的经验,尤其侧重于T1 / T2肿瘤,这可能是微创技术的候选人。方法1985年至2005年,对128例患者进行了一次外科手术治疗。使用Kaplan-Meier方法计算总生存率(OS),疾病特异性生存率(DSS)和无复发生存率(RFS),并通过单因素和多因素分析来分析预测因素。结果五年OS,DSS和RFS比率分别为60%,70%和61%。多变量分析显示病理性T分类和囊外延伸(ECE)是DSS的重要预测指标,而T分类对于局部复发仍很重要。 T1 / T2肿瘤的DSS为77%(淋巴结阳性)至84%(淋巴结阴性)。结论T分类和ECE是BOT SCC结局的独立预测因子。 cT1 / T2肿瘤患者的预后极好,可能适合经口机器人或内窥镜手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号